Estrella Immunopharma, Inc. — 10-Q Filings
13 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Estrella Immunopharma, Inc. (ESLAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Estrella Immunopharma, Inc. has filed 13 10-Q documents with the SEC since 2021. To view all SEC filings by Estrella Immunopharma, Inc., see the full filings list.
All
10-K
10-K/A
10-KT
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-Q
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 0001213900-25-109198 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-074567 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-043365 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-098450 | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-043126 | May 15, 2024 | Mar 31, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-014191 | Feb 14, 2024 | Dec 31, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-088827 | Nov 20, 2023 | Sep 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-061563 | Aug 1, 2023 | Jun 30, 2023 |
| 10-Q | FORM 10-Q | 0001575872-23-000781 | May 18, 2023 | Mar 31, 2023 |
| 10-Q | FORM 10-Q | 0001575872-22-001112 | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001410578-22-002124 | Aug 8, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001410578-22-001647 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001410578-21-000091 | Nov 10, 2021 | Sep 30, 2021 |